D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Barings BDC
BBDC
$994M
| $318K | ﹤0.01% |
42,505
-55,052
| -56% | -$412K |
|
2227
Civeo
CVEO
$293M
| $318K | ﹤0.01% |
64,265
-47,620
| -43% | -$236K |
|
2228
Brady Corp
BRC
$3.74B
| $316K | ﹤0.01% |
6,992
-25,789
| -79% | -$1.17M |
|
2229
Ecovyst
ECVT
$1.07B
| $312K | ﹤0.01% |
+28,644
| New | +$312K |
|
|
AMRN
2230
Amarin Corp
AMRN
$309M
| $311K | ﹤0.01% |
3,885
-47,744
| -92% | -$3.82M |
|
2231
Calavo Growers
CVGW
$494M
| $311K | ﹤0.01% |
5,384
-52,335
| -91% | -$3.02M |
|
2232
AC Immune
ACIU
$236M
| $310K | ﹤0.01% |
+44,914
| New | +$310K |
|
2233
OrthoPediatrics
KIDS
$505M
| $307K | ﹤0.01% |
7,742
-5,324
| -41% | -$211K |
|
|
FLIC
2234
DELISTED
First of Long Island Corp
FLIC
| $306K | ﹤0.01% |
17,659
+4,251
| +32% | +$73.7K |
|
2235
Sony
SONY
$174B
| $305K | ﹤0.01% |
25,730
-11,305
| -31% | -$134K |
|
|
TGH
2236
DELISTED
Textainer Group Holdings limited
TGH
| $304K | ﹤0.01% |
36,932
-103,261
| -74% | -$850K |
|
|
BSTC
2237
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $304K | ﹤0.01% |
5,369
-1,400
| -21% | -$79.3K |
|
2238
MarineMax
HZO
$566M
| $302K | ﹤0.01% |
+28,990
| New | +$302K |
|
|
SUP
2239
DELISTED
Superior Industries International
SUP
| $302K | ﹤0.01% |
251,781
-90,959
| -27% | -$109K |
|
2240
Wave Life Sciences
WVE
$1.12B
| $301K | ﹤0.01% |
32,112
+9,564
| +42% | +$89.6K |
|
|
XIFR
2241
XPLR Infrastructure, LP
XIFR
$946M
| $301K | ﹤0.01% |
+7,000
| New | +$301K |
|
2242
Culp
CULP
$58M
| $300K | ﹤0.01% |
40,770
+2,213
| +6% | +$16.3K |
|
2243
Fidus Investment
FDUS
$754M
| $300K | ﹤0.01% |
45,385
+33,273
| +275% | +$220K |
|
2244
BancFirst
BANF
$4.47B
| $299K | ﹤0.01% |
+8,974
| New | +$299K |
|
2245
XBiotech
XBIT
$86M
| $298K | ﹤0.01% |
28,105
-147,684
| -84% | -$1.57M |
|
|
Y
2246
DELISTED
Alleghany Corporation
Y
| $297K | ﹤0.01% |
537
-454
| -46% | -$251K |
|
|
DX
2247
Dynex Capital
DX
$1.64B
| $296K | ﹤0.01% |
28,375
-7,646
| -21% | -$79.8K |
|
2248
First Merchants
FRME
$2.32B
| $296K | ﹤0.01% |
+11,162
| New | +$296K |
|
2249
Gerdau
GGB
$6.23B
| $296K | ﹤0.01% |
+195,329
| New | +$296K |
|
|
GOOD
2250
Gladstone Commercial Corp
GOOD
$605M
| $296K | ﹤0.01% |
+20,606
| New | +$296K |
|